These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 26953343)

  • 1. Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).
    Zhou N; Pan T; Zhang J; Li Q; Zhang X; Bai C; Huang F; Peng T; Zhang J; Liu C; Tao L; Zhang H
    J Biol Chem; 2016 Apr; 291(17):9218-32. PubMed ID: 26953343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
    Chen D; Hou Z; Jiang D; Zheng M; Li G; Zhang Y; Li R; Lin H; Chang J; Zeng H; Guo JT; Zhao X
    Emerg Microbes Infect; 2019; 8(1):1511-1523. PubMed ID: 31631785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
    Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
    J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L.
    Yu F; Pan T; Huang F; Ying R; Liu J; Fan H; Zhang J; Liu W; Lin Y; Yuan Y; Yang T; Li R; Zhang X; Lv X; Chen Q; Liang A; Zou F; Liu B; Hu F; Tang X; Li L; Deng K; He X; Zhang H; Zhang Y; Ma X
    Front Microbiol; 2022; 13():884034. PubMed ID: 35572668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
    Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
    J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle East Respiratory Syndrome Coronavirus Spike Protein Is Not Activated Directly by Cellular Furin during Viral Entry into Target Cells.
    Matsuyama S; Shirato K; Kawase M; Terada Y; Kawachi K; Fukushi S; Kamitani W
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
    Shirato K; Kanou K; Kawase M; Matsuyama S
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teicoplanin inhibits Ebola pseudovirus infection in cell culture.
    Wang Y; Cui R; Li G; Gao Q; Yuan S; Altmeyer R; Zou G
    Antiviral Res; 2016 Jan; 125():1-7. PubMed ID: 26585243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitors targeting coronavirus and filovirus entry.
    Zhou Y; Vedantham P; Lu K; Agudelo J; Carrion R; Nunneley JW; Barnard D; Pöhlmann S; McKerrow JH; Renslo AR; Simmons G
    Antiviral Res; 2015 Apr; 116():76-84. PubMed ID: 25666761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.
    Shah PP; Wang T; Kaletsky RL; Myers MC; Purvis JE; Jing H; Huryn DM; Greenbaum DC; Smith AB; Bates P; Diamond SL
    Mol Pharmacol; 2010 Aug; 78(2):319-24. PubMed ID: 20466822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease.
    Wong G; Liu W; Liu Y; Zhou B; Bi Y; Gao GF
    Cell Host Microbe; 2015 Oct; 18(4):398-401. PubMed ID: 26468744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
    Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
    PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanisms.
    Adedeji AO; Severson W; Jonsson C; Singh K; Weiss SR; Sarafianos SG
    J Virol; 2013 Jul; 87(14):8017-28. PubMed ID: 23678171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
    Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
    Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV.
    V K P; Rath SP; Abraham P
    PLoS One; 2021; 16(5):e0251913. PubMed ID: 34003827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors.
    Ma L; Li Y; Shi T; Zhu Z; Zhao J; Xie Y; Wen J; Guo S; Wang J; Ding J; Liang C; Shan G; Li Q; Ge M; Cen S
    Biomed Pharmacother; 2023 Feb; 158():114213. PubMed ID: 36916436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.